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Abstract   
 
Morphological studies have shown that macrophages and microglia undergo apoptosis in the 
central nervous system (CNS) in acute experimental autoimmune encephalomyelitis (EAE) in 
the Lewis rat. To assess the relative levels of macrophage and microglial apoptosis, and the 
molecular mechanisms involved in this process, we used three-colour flow cytometry to 
identify CD45lowCD11b/c+ microglial cells and CD45highCD11b/c+ macrophages in the 
inflammatory cells isolated from the spinal cords of Lewis rats 13 days after immunization 
with myelin basic protein (MBP) and complete Freund’s adjuvant. Simultaneously, we 
analyzed the DNA content of these cell populations to assess the proportions of cells 
undergoing apoptosis and in different stages of the cell cycle or examined their expression of 
three apoptosis-regulating proteins, i.e. Fas (CD95), Fas ligand (FasL) and Bcl-2. Microglia 
were highly vulnerable to apoptosis and were over-represented in the apoptotic population. 
Macrophages were less susceptible to apoptosis than microglia and underwent mitosis more 
frequently than microglia. The different susceptibilities of microglia and macrophages to 
apoptosis did not appear to be due to variations in Fas, FasL or Bcl-2 expression, as the 
proportions of microglia and macrophages expressing these proteins were similar, and were 
relatively high. Furthermore, in contrast to T cell apoptosis, apoptosis of 
microglia/macrophages did not occur more frequently in cells expressing Fas or FasL, or less 
frequently in cells expressing Bcl-2. These results indicate that the apoptosis of microglia and 
CNS macrophages in EAE is not mediated through the Fas pathway, and that Bcl-2 
expression does not protect them from apoptosis. Expression of FasL by macrophages and 
microglia may contribute to the pathogenesis and immunoregulation of EAE through 
interactions with Fas+ oligodendrocytes and Fas+ T cells. The high level of microglial 
apoptosis in EAE indicates that microglial apoptosis may be an important homeostatic 
mechanism for controlling the number of microglia in the CNS following microglial 
activation and proliferation.    
 
Introduction 
Apoptosis (programmed cell death) of inflammatory cells occurs in the central nervous 
system (CNS) in experimental autoimmune encephalomyelitis (EAE) (1–3). EAE is a T cell-
mediated inflammatory demyelinating disease of the CNS and is an animal model of 
multiple sclerosis. It can be induced in susceptible animals by immunization with myelin 
antigens, such as myelin basic protein (MBP), and adjuvants or by the passive transfer of T 
lymphocytes activated by these antigens (4). The encephalitogenic T cells release cytokines 
(5) that attract and activate other cells, including macrophages which are essential for the 
pathogenesis of EAE (6). Activated macrophages phagocytose myelin and act as antigen-
presenting cells (APC) in the CNS in EAE (7–9). Microglia, the resident tissue macrophages 
of the CNS, also become activated and express increased levels of class II MHC molecules 
during the course of EAE (10–12) but are not effective APC in vitro (13). 
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We have previously reported that in acute EAE in the Lewis rat, encephalitogenic 
Vβ8.2+ MBP-reactive T cells are selectively eliminated from the CNS by apoptosis 
and that this contributes to the spontaneous clinical recovery from EAE (14–16). We 
have also provided evidence that the apoptosis of autoreactive T cells in the target 
organ of this autoimmune disease represents activation-induced cell death through the 
Fas (CD95) pathway (17). Morphological studies using immunocytochemical 
techniques have shown that, in addition to T cells, CD11b/c+ cells 
(macrophages/microglia) undergo apoptosis in the CNS in EAE (18); however, these 
studies were not able to distinguish definitively between apoptotic macrophages and 
apoptotic microglia. In an earlier study, using standard light and electron microscopy 
we demonstrated apoptotic macrophages in the CNS in EAE, particularly in chronic 
persistent EAE, on the basis of the presence of myelin debris within apoptotic cells 
(19). One possible mechanism for the apoptosis of macrophages and microglia in EAE 
is involvement of the Fas pathway, as in the case of T cells (17). Ashany and 
colleagues (20) have demonstrated that Fas expression is up-regulated on activated 
macrophages and that they are thus prone to Fas-mediated cytotoxicity by CD4+ T 
cells expressing Fas ligand (FasL). The present study was undertaken to quantify CNS 
macrophage and microglial apoptosis in EAE, to determine whether these cells 
express Fas and FasL, and to determine whether Fas plays a role in 
macrophage/microglial apoptosis as it does in the apoptotic deletion of autoreactive T 
cells in the CNS during spontaneous recovery from EAE. 
 
Methods  
Animals 
Female Lewis rats (JC strain), 7–10 weeks old, were obtained from the Central 
Animal Breeding House of the University of Queensland. 
 
Preparation of inoculum and induction of EAE 
MBP was prepared from guinea pig brains by the method of Deibler et al. (21). MBP 
in 0.9% saline was emulsified in an equal volume of incomplete Freund’s adjuvant 
containing 4 mg/ml Mycobacterium butyricum. Under anaesthesia, rats were 
inoculated in a footpad of one hindfoot with 0.1 ml emulsion. The total dose of MBP 
was 50 µg per rat. 
 
Clinical assessment 
Tail, hindlimb and forelimb weakness were each graded on a scale of 0 (no weakness) 
to 4 (total paralysis) as previously described (22). The total clinical score was 
obtained by adding these three scores (maximum = 12). 
 
Extraction of c e l l s  from the spinal cord 
On day 13 after inoculation, cells were isolated from the spinal cords of rats perfused 
with ice-cold saline using our previously described methods (14). The entire spinal 
cord was removed by insufflation, weighed and a single-cell suspension in ice-
cold RPMI containing 1% FCS was prepared by passage of the spinal cord 
through a 200-mesh stainless steel sieve. The cell suspension was mixed with 
isotonic Percoll (Percoll:HBSS 9:1) in a 3:2 ratio (density 1.052) in 50 ml 
centrifuge tubes and spun for 25 min at 640 g at 4°C. The cell pellet and the 
last 9 ml supernatant were resuspended, transferred to a conical centrifuge tube, 
underlaid with 1 ml Ficoll and spun for 20 min at 600 g at 4°C. The cells from the 
interface above the Ficoll were collected, washed and counted. Because the 
present study was focussed on macrophages and microglia, we did not pass the 
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spinal cord inflammatory cells through a nylon wool column to enrich for T 
lymphocytes as we have done in previous studies (14,16,17). 
 
Antibodies 
Mouse mAb specific for CD45 (OX1; leukocyte common antigen), CD5 (OX19; T 
lymphocytes), αβ TCR (R73), CD8α (OX8; cytotoxic/suppressor T cells, NK cells 
and a subset of dendritic cells), NKR-P1A (10/78; NK cells), CD45RA or A/B (OX33; 
B lymphocytes) were obtained from Dr J. Sedgwick. Antibody to Vβ8.2 (R78) was 
kindly provided by Dr T. Hünig (23). Rabbit polyclonal antibodies specific for rat Fas 
(M-20), FasL (N-20) and Bcl-2 (N-19) were purchased from Santa Cruz 
Biotechnology (Santa Cruz, CA). The directly labelled antibodies employed were 
mouse phycoerythrin (PE)-conjugated anti-rat CD11b/c (PharMingen, San Diego, CA) 
and mouse FITC-conjugated anti-rat CD8α (Serotec, St Louis, MO). The secondary 
antibodies employed were FITC-conjugated sheep anti-mouse IgG (Sigma, St Louis, 
MO), FITC-conjugated goat anti-rabbit IgG F(ab’)2 (Rockland, Gilbertsville, PA), PE-
conjugated goat anti-mouse Ig (Dako, Glostrup, Denmark), PE-conjugated goat anti-
rabbit IgG (Sigma) and TriColor-conjugated goat anti-mouse IgG1 (Caltag, San 
Francisco, CA). Mouse IgG1 (Dako) and rabbit IgG (Rockland) were used as control 
antibodies. The primary and secondary antibodies were diluted in PBS/azide (1% 
FCS/1% sodium azide in PBS) plus 10% autologous rat serum. 
 
L a b e l i n g  of c e l l s  and f l o w  cytometric analysis 
Three-colour analysis was used for the simultaneous detection of surface and 
intracellular antigens, and for analysis of DNA content for assessment of apoptosis. 
Briefly, 105–106 cells were stained for expression of cell surface antigens as 
previously described (16). The cells were then incubated with mouse Ig for 10 min at 
4°C to prevent any free fluorochrome-conjugated anti-mouse Ig secondary antibodies 
from binding to the PE-conjugated mouse anti-rat CD11b/c and FITC-conjugated 
mouse anti-rat CD8α antibodies which were added to certain cell samples in the next 
step (30 min at 4°C in the dark). After washing, cells were fixed with 1 ml ice-cold 
0.25% paraformaldehyde in PBS (pH 7.2) overnight at 4°C. They were then washed in 
PBS and permeabilized by being gently resuspended in 1 ml 0.2% Tween 20 in PBS 
and incubated at 37°C for 15 min. Samples were washed and the intracellular antigen 
Bcl-2 was labelled in the same manner as for the surface antigens. If DNA staining 
was to be performed, the washed samples were then resuspended in an appropriate 
volume (100–300 µl) of propidium iodide (PI)-staining solution which was freshly 
prepared by diluting stock solution [RNase (5 mg/ml) and PI (250 µg/ml) in 0.1 M 
PBS containing 0.1 mM EDTA, pH 7.4] with PBS/azide. Samples were kept on ice in 
the dark and analyzed within 1 h. Immunofluorescence and DNA analysis were 
performed on a FACSCalibur using CellQuest software (Becton Dickinson, Mountain 
View, CA), which was routinely calibrated using Becton Dickinson CaliBRITE flow 
cytometry beads and FACSComp software. Electronic compensation for three-colour 
analysis ensured unchanged FITC and PE distributions following TriColor labelling of 
antigens or PI labelling of DNA. For each sample, 40,000 events were scored. To 
avoid detecting nuclear debris, events with a low level of PI f luorescence were not 
collected. For surface and intracellular antigen labelling, the Ig-control sample values 
were subtracted from all other sample values to remove FITC, PE and TriColor 
background fluorescence. Apoptotic events were defined as those having a lower PI 
fluorescence than the sharply defined G0/G1 peak. 
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Table 1. Phenotype of spinal cord inflammatory cells 13 days after 
inoculation 
 
aEach group comprised five to seven rats. 
 
Statistical analysis 
Percentages of the different inflammatory cell populations which were apoptotic or 
which expressed Fas, FasL or Bcl-2 were compared using ANOVA to compare all cell 
populations simultaneously, followed by Student’s t-test to compare pairs of cell 
populations. 
 
 
 
 
Fig. 1. (A) Representative flow cytometric histogram of CNS-infiltrating cells extracted from the 
spinal cords of rats 13 days after inoculation and double stained for CD45 and CD11b/c, showing 
CD45 expression by CD11b/c+ cells, with typical analysis gates (MG = microglia; MO = 
macrophages). (B) DNA staining profiles of the total inflammatory cell population (total cells) and the 
CD45lowCD11b/c+ (microglia) and CD45highCD11b/c+ (macrophage) populations shown in (A). The 
numbers in the profiles represent the percentages of apoptotic (Ao) and non-apoptotic (Non-Ao) cells 
in each population. 
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Results 
Spinal cord inflammatory cell phenotype 
Pooled spinal cord inflammatory cells were analyzed on day 13 after inoculation 
(previous studies have shown that the peak of clinical disease occurs on days 12–14 
after inoculation) from 13 groups of rats with five to seven rats per group. The mean 
total clinical score was 4.8 ± 0.9, with the mean day of onset being 9.6 ± 0.7. The 
phenotypes of the spinal cord inflammatory cells isolated from these rats are shown in 
Table 1. Haemopoietic (CD45+) cells constituted 81.6% of the total extracted cell 
population. Of the CD45+ population, 48% were CD5+ (T lymphocytes), 20% were 
CD45RA or A/B+ (B lymphocytes), 3% were NKR-P1A+ (NK cells), 10% were 
CD45lowCD11b/c+ (microglia) and 17% were CD45highCD11b/c+ (macrophages), with the 
last two cell types, which are both CD11b/c+, being identified according to their level of 
expression of CD45 (Fig. 1A) (24,25). 
 
 
 
Fig. 2. Percentages of the total CNS-infiltrating cell population (total), the microglial 
(CD45lowCD11b/c+) population and the macrophage (CD45highCD11b/c+) population in the different 
phases of the cell cycle, including apoptosis, in rats with EAE 13 days after inoculation. The values for 
the G0/G1 and S/G2/M phases of the cell cycle were calculated from one experiment. The ANOVA P 
value for the comparison of apoptosis in the three cell populations was <0.001. Student’s t-test 
indicated that there were significant differences in the levels of apoptosis when comparisons were made 
within each pair of cell populations (microglia versus total, P = 0.01; microglia versus macrophages, P 
< 0.001; macrophages versus total, P < 0.001). (G0 = resting; G1 = pre-DNA synthesis; S = DNA 
synthesis; G2 = period between DNA synthesis and mitosis; M = mitosis). 
 
Apoptosis of microglia and macrophages 
To determine the susceptibility of microglia and macrophages to apoptosis, we 
employed simultaneous flow cytometric analysis of surface antigens and DNA content. 
Figure 1(B) shows representative DNA staining of the total inflammatory cell 
population, CD45lowCD11b/c+ cells and CD45highCD11b/c+ cells, and Fig. 2 shows the 
means and population SD of the percentages of these three populations undergoing 
apoptosis. The proportion of the CD45lowCD11b/c+ cells (microglia) undergoing 
apoptosis was higher than the proportion of the total inflammatory cell population 
undergoing apoptosis and much higher than the proportion of CD45highCD11b/c+ cells 
(macrophages) undergoing apoptosis. The average ratio of the percentage of microglia 
undergoing apoptosis to the percentage of macrophages undergoing apoptosis in seven 
separate experiments was 7:1. These results indicate that microglia are highly 
vulnerable to apoptosis and that macrophages are relatively resistant to apoptosis, 
when compared with the total inflammatory cell population. The vulnerability of 
microglia to apoptosis was also indicated by a 2.4 ± 1.4-fold enrichment of 
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CD45lowCD11b/c+ cells in the total apoptotic population compared to the total non-
apoptotic population. In contrast, CD45highCD11b/c+ cells were under-represented in 
the total apoptotic population compared to the total non-apoptotic population (0.3 ± 
0.2). 
Figure 2 also shows the proportion of cells in the G0/G1 and S/G2/M phases of the cell 
cycle, and reveals that microglia and especially macrophages are proliferating more 
frequently than the total inflammatory cell population. 
 
 
 
Fig. 3. Percentages of the total CNS-infiltrating cell population (total), the microglial (MG) 
(CD45lowCD11b/c+) population and the macrophage (MO) (CD45highCD11b/c+) population expressing 
apoptosis-regulating proteins in rats with EAE 13 days after inoculation. The ANOVA P values for the 
comparison of the expression of each apoptosis-regulating protein by the three cell populations, 
together with the P values (Student’s t-test) for the comparisons of the pairs of cell populations, are 
shown directly below the apoptosis-regulating protein to which they refer. 
 
Expression of apoptosis-regulating proteins by microglia and macrophages 
We have recently shown that Fas+ T cells and FasL+ T cells are particularly prone to 
undergo apoptosis in the CNS in experimental autoimmune encephalomyelitis (EAE), 
whereas Bcl-2+ T cells are relatively resistant (17). To determine whether these 
apoptosis-regulating proteins play a similar role in microglial and macrophage 
apoptosis, we determined their expression by CD45lowCD11b/c+ cells (microglia) and 
CD45highCD11b/c+ cells (macrophages) (Fig. 3). The proportions of microglia 
expressing Fas, FasL or Bcl-2 were similar to the proportions of macrophages, and 
higher than the proportions of the total inflammatory cell population, expressing these 
proteins. Because our flow cytometer was limited to a maximum of three colours, we 
were unable to determine the proportions of apoptotic cells in the microglial and 
macrophage populations expressing apoptosis-regulating proteins. However, 85.2 6 
17.7% of CD11b/c+ cells were CD45+ (the remainder were probably endothelial cells) 
and expression of the apoptosis-regulating proteins by CD11b/c+ cells had no 
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relationship to the level of CD11b/c+ cell apoptosis observed (Table 2). These results 
indicate that the Fas pathway is not involved in the apoptosis of microglia and 
macrophages, and that Bcl-2 expression does not protect these cells from apoptosis. 
 
Table 2. Susceptibility of CD11b/c+ cells to apoptosis 
 
 
aMean and population SD. 
bFor each experiment the percentage of apoptotic cells in the CD11b/c+ population expressing the 
apoptosis-regulating protein was divided by the percentage of apoptotic cells in the CD11b/c+ population 
not expressing the protein. The mean and population SD of these values were then calculated. 
 
Discussion 
In the present study we have used flow cytometry to identify microglia and 
macrophages in the CNS in acute EAE on the basis of their expression of CD45 and 
CD11b/c, and we simultaneously have used DNA staining to identify apoptotic cells 
and cells at different stages of the cell cycle. At the clinical peak of acute EAE, we 
found both apoptotic microglia and apoptotic macrophages, which confirms our 
previous in situ studies (18,19). Furthermore, the present study has extended these 
observations to show that CD45lowCD11b/c+ microglia are highly vulnerable to 
apoptosis, whereas CD45highCD11b/c+ macrophages are less susceptible. As the 
density of some cell surface antigens is lower on apoptotic cells (defined by cell size) 
than on viable cells (26), it is possible that the level of CD45 expression on some 
apoptotic macrophages was reduced and that these cells were thus incorrectly 
classified as microglia. However, in CNS-infiltrating cells obtained from rats with EAE 
and enriched for T cells, the majority of apoptotic cells were CD45high, indicating that 
apoptotic cells are still capable of expressing high levels of CD45 (data not shown). 
We would therefore expect that only a small proportion of the apoptotic macrophages 
might have been incorrectly classified as CD45lowCD11b/c1 microglia, and that this 
would not account for the observed differences in the susceptibility of microglia and 
macrophages to apoptosis. 
 
We have also shown that microglia and CNS macrophages express Fas and FasL in 
EAE. However, the different susceptibilities of microglia and macrophages to 
apoptosis do not appear to be due to variations in Fas or FasL expression, or Bcl-2 
expression, as the proportions of microglia and macrophages expressing these 
apoptosis-regulating proteins were the same. Furthermore, CD11b/c+ cells (of which 
85% were also CD45+) expressing Fas, FasL or Bcl-2 underwent apoptosis to the same 
extent as CD11b/c+ cells not expressing these proteins. These results suggest that the 
Fas pathway, which mediates T cell apoptosis in the CNS in acute EAE (17), is not 
involved in the apoptosis of microglia and macrophages. Our study also suggests that 
microglial and macrophage apoptosis is not controlled by Bcl-2. This is similar to the 
findings of Gehrmann and Banati (27) who found that expression of b c l -2 and c-m y c  
was unchanged throughout a period of microglial activation, proliferation and 
apoptosis in the CNS following peripheral nerve injury. 
 
Non-Fas-dependent mechanisms which may be responsible for the microglial and 
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macrophage apoptosis include: the effect of NO which induces macrophage apoptosis 
in vitro (28, 29), although microglia have been reported to be resistant to NO-induced 
damage (30, 31); the release of down-regulatory cytokines such as IL-4, IL-6 and 
transforming growth factor-β (32–34); and the withdrawal of pro-inflammatory 
cytokines such as IL-1, tumour necrosis factor-α and IFN-γ , which are produced in 
the CNS in EAE (5,35), or colony stimulating factors, which are produced by 
stimulated astrocytes (36) and which prevents monocyte and microglial apoptosis in 
vitro (37,38). Withdrawal of T cell-derived cytokines could occur when T cells die by 
apoptosis or are inhibited by other means. One possible explanation for the different 
susceptibilities of microglia and macrophages to apoptosis could be the differential 
expression of CD40 which, when ligated, may provide protection from apoptosis (39). 
A lack of CD40 expression by microglia could possibly account for their greater 
vulnerability to apoptosis. 
 
We also found that macrophages and microglia undergo mitosis more frequently than 
the total inflammatory cell population. Furthermore, in contrast to our findings on 
apoptosis, the proportion of macrophages undergoing mitosis was twice the proportion 
of microglia undergoing mitosis. Microglial/macrophage proliferation during EAE has 
previously been reported (12,40–42). Reid and colleagues (43) demonstrated that 
microglia in the normal CNS are activated and induced to proliferate or undergo 
apoptosis after exposure to an anti-CD11b/CD18 antibody. They suggested that the 
apoptosis occurred because of a lack of the growth factors necessary to support a 
sustained microglial proliferative response. As suggested above, macrophages may 
possess some mechanism which protects them from the apoptotic fate of microglia 
and allows continuation of proliferation. The ultimate fate of these CNS macrophages 
is unclear, as the low incidence of macrophage apoptosis observed in the present 
study suggests that this mechanism may play only a minor role in their removal from 
the CNS. It is likely that they emigrate from the site of inflammation, as observed in a 
murine model of resolving peritonitis (44). The high level of microglial apoptosis in 
EAE indicates that microglial apoptosis may be an important homeostatic mechanism 
for controlling the number of microglia in the CNS following microglial activation and 
proliferation. 
 
Our finding that relatively high proportions of microglia and macrophages express 
FasL compared to the total CNS inflammatory cell population in EAE may have 
implications for the pathogenesis of this disease. Recent studies have shown that the 
interaction between Fas and FasL is necessary for the development of EAE (45,46). 
FasL+ macrophages and microglia, in addition to FasL+ T cells, could contribute to the 
development of demyelination by damaging Fas+ oligodendrocytes. 
 
The expression of FasL by microglia could also have immunoregulatory effects by 
contributing to the activation-induced apoptosis of T cells, as the expression of FasL 
in some organs, such as the testis (47) and the eye (48), has been suggested to mediate 
immune privilege by inducing apoptosis of infiltrating Fas+ lymphocytes. This could 
add to the T cell apoptosis resulting from the interaction between Fas and FasL on the 
same T cell (17). A detailed understanding of the process of inflammatory cell 
elimination and how it might fail in chronic autoimmune disorders may lead to a 
better understanding of diseases such as multiple sclerosis. 
 
Acknowledgements 
This work was supported by a project grant from the National Health and Medical Research Council of 
Australia. We would like to thank Dr T. Hu¨nig and Dr J. Sedgwick for providing mAb, Grace Chojnowski 
for her assistance with the flow cytometry work, and Lynn Mallard for general technical assistance. 
 
Abbreviations 
International Immunology, (1998) 10 (7): 935-941.  
APC  antigen-presenting cells 
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